54 online
 
Most Popular Choices
Share on Facebook 17 Printer Friendly Page More Sharing
OpEdNews Op Eds    H3'ed 5/19/12

Giulio Meotti: Serial Plagiarist or Common Hasbarist?

By       (Page 2 of 2 pages) Become a premium member to see this article and all articles as one long page.   1 comment
Message Max Blumenthal
Become a Fan
  (16 fans)

This piece was reprinted by OpEd News with permission or license. It may not be reproduced in any form without permission or license from the source.

"Research by a professor at the Weizmann Institute has led to the development of promising new therapies for acute spinal cord injuries. The late actor Christopher Reeve described Israel as the 'world-center' for research on paralysis treatment."

Meotti is so bereft of originality that he even plagiarizes himself: He pasted a long section from a February 24, 2012 column about how "music can be a platform for anti-Semitism" into a piece he published two months later about anti-Semites in Hollywood working to destroy Israel.
 
The remarkable thing about Meotti's plagiarism scandal is that it is not being treated as much of a scandal at all. Yedioth Aharanot, the parent company of YNet, has apparently not taken any punitive measures against Meotti. And neither Kirchick nor Stephens expressed any outrage about being plagiarized. Instead, Kirchick dismissed Meotti's stealing as "a form of flattery" and Stephens, who also said he was "flattered," said Meotti's column "makes a point worth repeating." Their startling reactions reflect a neoconservative culture in which the cause of Greater Israel supersedes everything else, from journalistic ethics to intellectual originality.
 
Because Kirchick, Stephens and Meotti draw their arguments from the same storehouse of recycled Likudnik hasbara, their columns are virtually indistinguishable and completely interchangeable. If any one of them disappeared, some other pro-Israel cadre could step into their shoes without anyone noticing. As Meotti demonstrated, it takes little more than cutting and pasting press releases from Israel advocacy groups to succeed in the world of neoconservatism.

Next Page  1  |  2

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Max Blumenthal Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Max Blumenthal is an award-winning journalist and the author of several books, including best-selling Republican GomorrahGoliathThe Fifty One Day War, and The Management of Savagery. He has produced print articles for an array of (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Watch: Israeli Gov't Calls for "Civil Elimination" of Left-Wing Activists and Roseanne Barr Goes on a Rampage

Progressive Democratic hero Elizabeth Warren enlists to serve AIPAC's pro-war agenda

Inside the Twisted Police Department That Kills Unarmed Citizens at the Highest Rate in the Country

Inside The Strange Hollywood Scam That Spread Chaos Across The Middle East

You Will Be Surprised Who the Outside Agitators Really Are in Baltimore

Shocking "Extermination" Fantasies By the People Running America's Empire on Full Display at Aspen Summit

To View Comments or Join the Conversation:

Tell A Friend